TLRY - Tilray Brands, Inc.

7.15
0.290   4.056%

Share volume: 5,075,315
Last Updated: 04-20-2026
Pharmaceutical Products/Medicinal Chemicals: -0.15%

PREVIOUS CLOSE
CHG
CHG%
$6.86
0.29
0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
55%
Profitability 50%
Dept financing 36%
Liquidity 31%
Performance 70%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
5.30%
1 Month
10.85%
3 Months
-17.53%
6 Months
383.11%
1 Year
1,497.41%
2 Year
796.66%
Key data
Stock price
$7.15
P/E Ratio 
0.00
DAY RANGE
$6.81 - $7.23
EPS 
-$2.10
52 WEEK RANGE
$0.35 - $15.70
52 WEEK CHANGE
$1,461.48
MARKET CAP 
916.909 M
YIELD 
N/A
SHARES OUTSTANDING 
116.549 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-28-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$3,287,001
AVERAGE 30 VOLUME 
$3,114,427
Company detail
CEO: Irwin D. Simon
Region: US
Website: tilray.com
Employees: 1,700
IPO year: 2018
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. The company operates Tilray Medical, which provides GMP-certified flowers, oils, vapes, edibles, and topicals.

Recent news